Skip to content

PAVmed Inc.

PAVM · XNAS

CIK 1624326fmd_1R2H96RH4D42PG2Q4BRYSRA3V6Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2015 to Jun 30, 2026, 46 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues–––––10330
Cost of revenue–––––14650
Gross profit–––––(0)(3)(4)(2)(0)
Research and development23471120251464
Selling, general and administrative––––123461493617
Total operating expenses6811142354––––
Operating income(6)(8)(11)(14)(23)(54)(91)(69)(44)(22)
Interest expense–1200–1100
Interest and investment income––––––––00
Other non-operating income (expense)–(1)(8)(3)(13)(2)(12)(10)7319
Income before taxes(6)(10)(18)(17)(36)(56)(103)(79)28(2)
Income tax expense––––––––00
Net income from continuing operations–(10)(18)–––––28(2)
Net income(6)(10)(18)(16)(34)(50)(89)(64)400
Net income to common shareholders(6)(10)(19)(17)(35)(51)(89)(66)32(4)
PAVmed Inc. (PAVM) financial statements · FinancialMD